29.47
-1.77%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shanghai Haohai Biological Technology Co
Its shares trade on Shanghai under the ticker 688366.SS. It has been listed since 30 April 2015. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.47bn and net income of CN¥251.0m. At that date it held total assets of CN¥6.72bn and shareholders' equity of CN¥5.42bn.
Shanghai Haohai Biological Technology Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2015-04-30. Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The firm mainly operates businesses in Mainland China.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 30 Apr 2015
- Employees
- 1,338
- Website
- 3healthcare.com ↗
Leadership
Pay as last reported
- Mr. Yongtai HouExecutive Chairman of the Board, since 2010CN¥1.3m
- Mr. Minjie TangFinance Director, Executive Director, since 2016CN¥1.2m
- Mr. Jianying WuGeneral Manager, Executive Director, since 2010CN¥1.5m
- Mr. Wenbin WangDeputy General ManagerCN¥765,100
- Mr. Jundong ZhangDeputy General ManagerCN¥934,600
- Ms. Yiyi ChenExecutive Director, since 2014CN¥1.1m
- Ms. Min TianSecretary of the Board, Joint Company SecretaryCN¥686,400
- Mr. Ming HuangNon-Executive DirectorCN¥100,000
- Ms. Jie YouNon-Executive Director
- Mr. Zhihong JiangIndependent Non-Executive DirectorCN¥100,000
- Mr. Hongbo ShenIndependent Non-Executive Director, since 2023
- Mr. Zhi SuIndependent Non-Executive DirectorCN¥100,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shanghai Haohai Biological Technology Co Ltd possesses several strengths that contribute to its competitive advantage in the market. These strengths include:
Weaknesses
- Despite its strengths, Shanghai Haohai Biological Technology Co Ltd also faces certain weaknesses that can hinder its growth and performance. These weaknesses include:
Opportunities
- Shanghai Haohai Biological Technology Co Ltd can leverage various opportunities to expand its market presence and enhance its business prospects. These opportunities include:
Threats
- Shanghai Haohai Biological Technology Co Ltd must also be mindful of potential threats that could impact its business operations and performance. These threats include:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.